1. Home
  2. NTRA vs DRI Comparison

NTRA vs DRI Comparison

Compare NTRA & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • DRI
  • Stock Information
  • Founded
  • NTRA 2003
  • DRI 1968
  • Country
  • NTRA United States
  • DRI United States
  • Employees
  • NTRA N/A
  • DRI N/A
  • Industry
  • NTRA Medical Specialities
  • DRI Restaurants
  • Sector
  • NTRA Health Care
  • DRI Consumer Discretionary
  • Exchange
  • NTRA Nasdaq
  • DRI Nasdaq
  • Market Cap
  • NTRA 21.9B
  • DRI 25.5B
  • IPO Year
  • NTRA 2015
  • DRI 1995
  • Fundamental
  • Price
  • NTRA $138.90
  • DRI $204.48
  • Analyst Decision
  • NTRA Strong Buy
  • DRI Buy
  • Analyst Count
  • NTRA 16
  • DRI 24
  • Target Price
  • NTRA $185.56
  • DRI $227.08
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • DRI 1.3M
  • Earning Date
  • NTRA 08-07-2025
  • DRI 09-18-2025
  • Dividend Yield
  • NTRA N/A
  • DRI 2.94%
  • EPS Growth
  • NTRA N/A
  • DRI 4.26
  • EPS
  • NTRA N/A
  • DRI 8.87
  • Revenue
  • NTRA $1,831,000,000.00
  • DRI $12,076,700,000.00
  • Revenue This Year
  • NTRA $19.75
  • DRI $9.28
  • Revenue Next Year
  • NTRA $16.04
  • DRI $3.75
  • P/E Ratio
  • NTRA N/A
  • DRI $23.00
  • Revenue Growth
  • NTRA 51.50
  • DRI 6.03
  • 52 Week Low
  • NTRA $92.14
  • DRI $139.12
  • 52 Week High
  • NTRA $183.00
  • DRI $228.27
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 30.96
  • DRI 38.07
  • Support Level
  • NTRA $136.91
  • DRI $202.21
  • Resistance Level
  • NTRA $142.49
  • DRI $211.42
  • Average True Range (ATR)
  • NTRA 5.08
  • DRI 3.45
  • MACD
  • NTRA -1.82
  • DRI -0.95
  • Stochastic Oscillator
  • NTRA 7.18
  • DRI 13.93

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About DRI Darden Restaurants Inc.

Darden Restaurants is the largest restaurant operator in the US full-service space, with consolidated revenue of $12.1 billion in fiscal 2025. The company maintains a portfolio of 11 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, The Capital Burger, and most recently, Chuy's. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales through the traditional grocery channel contribute modestly. As of the end of its fiscal 2025, the company operated 2,159 restaurants in the US.

Share on Social Networks: